US Patent 12071454 Antigenic respiratory syncytial virus polypeptides
Patent 12071454 was granted and assigned to Sanofi on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+224 characters)
US Patent 12071454 Antigenic respiratory syncytial virus polypeptides
Article
Patent abstract
Antigenic respiratory syncytial virus (RSV) polypeptides for use in eliciting antibodies against RSV are provided. Also provided are antigenic polypeptides comprising an RSV polypeptide and a ferritin protein.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chih-Jen Wei0
Gary J. Nabel0
Kurt Swanson0
Magnus Besev0
Pradeep Dhal0
Ram Dharanipragada0
Date of Patent
August 27, 2024
0Patent Application Number
170610650
Date Filed
October 1, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12071454 Antigenic respiratory syncytial virus polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
